Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 12/19/2018
E.g., 12/19/2018
Title Status FDA Center Date Postedsort ascending
Incident Use of Hepatitis C Virus (HCV) Drugs Complete CDER 03/13/2018
Concomitancy and Indications for Idelalisib Use Complete CDER 03/13/2018
Prevalent and Incident Use of Generic Name Kinase Inhibitors Complete CDER 03/08/2018
Automated Approaches to Anaphylaxis Case Classification Using Unstructured Data Complete 03/07/2018
Incident Use of Rivaroxaban Complete CDER 03/07/2018
Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Discontinued CDER 03/06/2018
Sequential Surveillance for Drug Safety in a Regulatory Environment Complete 03/05/2018
Drug Utilization Over Time for Three Drug Classes Complete CDER 03/05/2018
Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Complete CDER 03/04/2018
Venous Thromboembolism after Continuous or Extended Cycle Contraceptive Use Complete CDER 03/04/2018
Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Complete CDER 03/02/2018
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products Complete CDER 03/02/2018
Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Complete CDER 03/01/2018
Data Quality Review and Characterization Programs v4.1.0 Complete 02/28/2018
Use of Tyrosine Kinase Inhibitors (TKIs) Complete CDER 02/28/2018
Length of Follow-up Time for New Users of Immunosuppressive Drugs Complete CDER 02/28/2018
Prevalent and Incident Dispensings of Ranolazine Complete CDER 02/26/2018
Testing Routine Querying Tools with Known Positive Exposure-Outcome Associations: Gastrointestinal (GI) Bleeding Following New Use of Warfarin Compared with Statins Complete 02/23/2018
Validation of Lymphoma in ICD-10-CM In progress 02/22/2018
Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use Complete CDER 02/05/2018
Ranexa (Ranolazine) and Seizures Complete CDER 02/05/2018
Sinus Stents with Mometasone and Diminished Visual Acuity Complete CDER 02/05/2018
Prevalent and Incident Use of SGLT2 Inhibitors Complete CDER 02/01/2018
Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers Complete CDER 02/01/2018
Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Complete CDER 02/01/2018
Antiepileptic Drug (AED) Injection Procedure Codes Complete CDER 01/31/2018
PROMPT: Rivaroxaban Surveillance Complete CDER 01/31/2018
Counts of Commonly used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers Complete CDER 01/29/2018
Drug and Medical Enrollment Counts Complete CDER 01/29/2018
Influenza Vaccines and Pregnancy Outcomes (PRISM) Complete CBER 01/26/2018
Use of Tumor Necrosis Factor (TNF) Blocker Drugs Complete CDER 01/26/2018
A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Complete CDER 01/26/2018
Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Complete CDER 01/25/2018
Conversion of Medicare Claims Synthetic Public Use Files (SynPUFs) to Sentinel Common Data Model (SCDM) Format Complete 01/25/2018
Molecularly Targeted Anti-Cancer Therapies Complete CDER 01/24/2018
Use of Stents Complete CDRH 01/23/2018
Stroke Diagnosis Codes Complete CDER 01/18/2018
Length of Enrollment in Pediatric Population Complete CDER 01/17/2018
Prevalent and Incident Use of Isotretinoin Complete CDER 01/16/2018
Occurrence of Selected Generic Drugs 13 Complete CDER 01/11/2018
Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Complete CDER 01/08/2018
Use of Dronedarone HCL Complete CDER 01/08/2018
Incident and Prevalent Dispensings of Mirabegron Complete CDER 01/01/2018
Use of Ospemifene, Boceprevir, and Telaprevir Complete CDER 12/29/2017
Postlicensure Medical Product Safety Data-Mining: Power Calculations for Bernoulli Data Complete CBER 12/22/2017
Prevalent and Incident Use of Testosterone Products Complete CDER 12/21/2017
Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Complete CDER 12/21/2017
Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Complete CDER 12/20/2017
Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Complete CDER 12/19/2017
Prevalent and Incident Use of Romiplostim Complete CDER 12/18/2017
Suicide Diagnoses Complete CDER 12/15/2017
Trends in Fibroid Surgery and Use of Power Morcellation Complete CDRH 12/14/2017
Incident and Prevalent Use of Generic Drugs for Overactive Bladder Complete CDER 12/11/2017
Use of Cancer Drugs Complete CDER 12/09/2017
Antipsychotic Use and Dementia Diagnoses Complete CDER 12/07/2017
Genetic Testing Procedures Complete CDER 12/05/2017
Atrial Fibrillation Prevalence Complete CDER 12/04/2017
Mycophenolate Dispensings and Procedures Complete CDER 12/01/2017
Mycophenolate Dispensings and Procedures (by Quarter) Complete CDER 12/01/2017
Development of Metrics to Assess Appropriate Prescribing of Opioids in the Mini-Sentinel Distributed Database (MSDD) Complete 11/20/2017
Validation of Serious Infections among an Immunocompromised Population In progress 11/19/2017
Influenza Vaccines and Febrile Seizures in the 2013-2014 and 2014-2015 Influenza Seasons Complete CBER 11/10/2017
Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Complete CDER 11/06/2017
Rapid Surveillance Capability: 2017-18 Seasonal Influenza Vaccines Surveillance In progress CBER 11/06/2017
Antipsychotics and Stroke (PSM) Complete CDER 11/02/2017
Antipsychotics/SSRIs and Stroke (PSM) Complete CDER 11/02/2017
Antipsychotics and Stroke Complete CDER 11/01/2017
Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification Complete CDER 10/30/2017
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products Complete CDER 10/12/2017
Alosetron Use Complete CDER 10/11/2017
Mirabegron Use Complete CDER 10/11/2017
Counts and Prevalence of 50 Venous Thromboembolism (VTE) Diagnosis Codes Complete CBER 10/09/2017
Pegylated Products Use Complete CDER 10/06/2017
Pegylated Products Follow-Up Request Complete CDER 10/06/2017
New Molecular Entities Complete CDER 10/04/2017